Related Experiment Video
Updated: Nov 11, 2025

12:19
Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
Published on: July 1, 2013
11.1K
Textured and Smooth Implant Use Reported in the Tracking Operations and Outcomes for Plastic Surgeons Database:
Evan Matros1, Meghana G Shamsunder1, Robyn N Rubenstein1
1Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, N.Y.
Plastic and Reconstructive Surgery. Global Open
|March 24, 2021
Summary
Textured breast implant use peaked in 2016, with rates decreasing significantly by 2019. This national trend suggests a potential future decrease in breast-implant-associated anaplastic large cell lymphoma (BIA-ALCL) cases.
Area of Science:
- Plastic Surgery
- Oncology
- Biomaterials
Background:
- Breast-implant-associated anaplastic large cell lymphoma (BIA-ALCL) is linked to textured implants.
- Existing research on textured implant use is limited to single-center data.
- National trends in smooth versus textured implant utilization require characterization.
Purpose of the Study:
- To analyze national trends in smooth versus textured breast implant utilization.
- To determine if textured implant use has decreased in recent years.
Main Methods:
- Utilized the Tracking Operations and Outcomes for Plastic Surgeons database (2007-2019).
- Calculated annual rates of smooth and textured implant use for cosmetic and reconstructive procedures.
- Employed generalized additive models and Pearson chi-square tests to assess trends.
Main Results:
- Textured implant use peaked in 2016 (17.83% cosmetic, 40.88% reconstructive).
- Textured implants were more common in reconstructive cases (2007-2009, 2011, 2013-2019).
- Rates decreased from 2017-2019; in 2019, use was 2.15% (cosmetic) and 7.58% (reconstructive).
Conclusions:
- This is the first national study on US breast implant texture trends.
- Peak textured implant use occurred in 2016.
- Anticipated peak BIA-ALCL cases may occur in 2026 or later, given the 10-year latency period.

